Advertisement
Choose date and time: ×
In the last hour
In the last 2 hours
In the last 4 hours
Burden and Boon The National Bureau of Asian Research03:35
Genexine chosen as Covid-19 vaccine developer Korea Biomedical Review03:28
In the last 6 hours
Sensorion reports 2020 first half results Business Wire (Press Release)01:34
Earlier today
In the last 8 hours
Yesterday
DOD Approves $87 Million for Newest Bioindustrial Manufacturing Innovation Institute US Department of Defense (Press Release)17:41 20-Oct-20
Aptinyx Announces Proposed Public Offering of Common Stock Business Wire (Press Release)16:11 20-Oct-20
Replimune Announces Proposed Public Offering GlobeNewswire (Press Release)16:11 20-Oct-20
Replimune Releases Updated Corporate Presentation GlobeNewswire (Press Release)16:01 20-Oct-20
WuXi AppTec: think ahead when dual-filing IND applications Outsourcing-Pharma.com12:05 20-Oct-20
Bid to put green projects in action The National, Scotland11:57 20-Oct-20
Covaxin: Bharat Bio gets approval for phase-III trials The Hindu Business Line11:47 20-Oct-20
Fueling the Biotech Pipeline Newswise (Press Release)11:45 20-Oct-20
Winners, losers of engineering law Daily Monitor11:21 20-Oct-20
Finding the next Vertex Evaluate Group10:58 20-Oct-20
Why Aptinyx Stock Is Soaring Today The Motley Fool10:58 20-Oct-20
GigaGen Announces Publication in the Peer-Reviewed Journal mAbs GlobeNewswire (Press Release)10:18 20-Oct-20
Authoritarianism and the Future of Technology The Epoch Times10:03 20-Oct-20
Mawi DNA Technologies Announces Partnership With Nucleus Biotech Business Wire (Press Release)09:08 20-Oct-20
Simulations Plus Releases GastroPlus® Version 9.8 Business Wire (Press Release)08:38 20-Oct-20
Vor Biopharma Appoints Matthew R. Patterson to its Board of Directors Business Wire (Press Release)08:07 20-Oct-20
Is Gilead Sciences a Good Coronavirus Stock? The Motley Fool08:07 20-Oct-20
view more headlines
21 Oct 05:36

Publication filters

Headline Density

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Sorry, no headlines or news topics were found. Please try different keywords.